Results 91 to 100 of about 23,984 (264)

Survival outcomes in dogs treated with vinorelbine‐based adjuvant treatment following surgical resection of grade II and III pulmonary carcinoma

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives Pulmonary carcinoma in dogs is commonly managed with surgical resection; however, the role of adjuvant chemotherapy for grade II and III carcinomas remains unclear. This retrospective multicentre study investigated the outcomes in dogs treated with vinorelbine‐based adjuvant treatment (as monotherapy or combined chemotherapy) following ...
N. Wong, L. Brockley, S. Rajan, J. Yu
wiley   +1 more source

Olanzapine –The cost-effective anti-emetic

open access: yesJournal of Dr. NTR University of Health Sciences
Introduction: Chemotherapy induced nausea and vomiting can be distressing when not adequately controlled. Many agents are used prophylactically to prevent CINV (Chemotherapy induced nausea and vomiting).
R Ramesh Reddy   +3 more
doaj   +1 more source

Antiemetic guidelines: are they being used?

open access: yes, 2005
Evidence-based guidelines are regarded as therapeutic standards for many medical interventions. However, implementation of such recommendations seems to be rather difficult.
Kaiser, R.
core   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Efficacy Of Ondansetron, Granisetron And Palonosetron On Post operative Nausea and Vomiting in Patients undergoing Elective Neurosurgical Procedure

open access: yesBasrah Journal of Surgery
Background Neurosurgery is associated with high incidence of PONV. 5HT3 Antagonists are highly specific for the treatment of nausea and vomiting. They are preferred antiemetic agents in neurosurgeries due to the lack of sedation and extrapyramidal ...
Vasudha Govil   +4 more
doaj   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

open access: yesObesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey   +7 more
wiley   +1 more source

Ondansetron per os in antiemetic therapy for gynecologic malignancies.

open access: yes, 1993
Ondansetron per os in antiemetic therapy for gynecologic ...
Donadello N   +4 more
core   +1 more source

Estudio farmacoeconómico de esquemas de tratamiento antiemético en quimioterapia moderada y altamente emetógena Pharmacoeconomic study of antiemetic treatment in moderate and highly emethogenic chemotherapy

open access: yesRevista Cubana de Medicina, 2010
INTRODUCCIÓN: Las náuseas y vómitos por quimioterapia (NVIQ) constituyen una complicación importante. La introducción de los antiserotoninérgicos 5HT3 (AR 5HT3 ) unida a los esteroides, ha posibilitado un mayor control de estos síntomas.
Noyde Batista Albuerne   +5 more
doaj  

Retrospective analysis of real‐world prescribing data for managing cisplatin‐based chemotherapy‐induced nausea and vomiting in China

open access: yesCancer Medicine
Background The current utilization of neurokinin‐1 receptor antagonists (NK1RAs) and the impact of updated guidelines on prescription patterns of antiemetic drugs among Chinese patients receiving highly emetogenic chemotherapy (HEC) remain undetermined ...
Xia Si   +5 more
doaj   +1 more source

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

open access: yes, 2018
A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer ...
P Hudson (13296588)   +9 more
core  

Home - About - Disclaimer - Privacy